| # | Drug | Count |
|---|---|---|
| 0 | RISANKIZUMAB-RZAA | 9 |
| 1 | ETANERCEPT | 5 |
| 2 | ROSUVASTATIN | 4 |
| 3 | ALENDRONATE SODIUM | 3 |
| 4 | ATORVASTATIN CALCIUM | 3 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 3 |
| 6 | FLUTICASONE PROPIONATE | 3 |
| 7 | GABAPENTIN | 3 |
| 8 | IBUPFROFEN | 3 |
| 9 | IBUPROFEN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAXOLOL | 1 | 0.0012 |
| 1 | CEFIXIME | 1 | 0.0003 |
| 2 | GLYCOPYRROLATE | 1 | 0.0002 |
| 3 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 2 | 0.0002 |
| 4 | ASENAPINE MALEATE | 1 | 0.0001 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 6 | CANAKINUMAB | 1 | 0.0001 |
| 7 | AMLODIPINE BESYLATE AND VALSARTAN | 1 | 0.0001 |
| 8 | CALCIUM GLUCONATE | 1 | 0.0001 |
| 9 | ERGOCALCIFEROL | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Interleukin-23 Antagonist [EPC] | 12 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 9 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |